(182)developed a nanoemulsion containing selenocysteine and TGF-β antagonists, effectively inhibiting TGF-β/TGF-βRI/Smad2/3 signal transduction and enhancing the upregulation of NKG2DL on cancer cells. Here, TGFB1 is linked to cancer.